VALE3:BMFBOVESPAVale S.A. Analysis
Data as of 2026-03-10 - not real-time
R$79.26
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Vale S.A. trades at R$79.26, well above its 20‑day SMA of R$85.97 and 50‑day SMA of R$82.05, yet still above the longer‑term 200‑day SMA of R$64.37, indicating a mixed technical picture. The RSI of 37 suggests the stock is approaching oversold territory, while the MACD remains bearish, and volume is on a decreasing trend, hinting at limited short‑term upside. Fundamentally, the company boasts a strong dividend yield of 8.74% but a payout ratio exceeding 200%, raising concerns about sustainability. The DCF fair value of roughly R$33.7 is far below the current price, flagging the stock as overvalued with limited upside. Despite a modest revenue growth of 0.5% and solid operating margins, the high debt‑to‑equity ratio (over 60%) and a beta below 1 point to moderate market sensitivity but heightened financial leverage. The “Extreme Greed” sentiment index reflects bullish market mood, yet the 30‑day volatility of 38% underscores significant price swings. In the medium to long term, Vale’s strategic shift toward energy‑transition materials and its dominant position in iron ore provide a foundation for growth, but regulatory scrutiny in Brazil and the unsustainable dividend policy temper enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering near support at R$76.55
- Bearish MACD and decreasing volume
- RSI indicating potential oversold condition
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Current price significantly above DCF fair value
- High dividend payout ratio (>200%) questioning sustainability
- Stable operating margins but modest revenue growth
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Strategic diversification into energy‑transition minerals
- Long‑term demand for iron ore and base metals
- Potential upside if dividend policy is restructured and debt is managed
Key Metrics & Analysis
Financial Health
Revenue Growth0.50%
Profit Margin6.47%
P/E Ratio27.2
ROE5.87%
ROA7.79%
Debt/Equity61.33
P/B Ratio1.8
Op. Cash FlowR$48.8B
Free Cash FlowR$15.4B
Technical Analysis
TrendBullish
RSI37.4
SupportR$76.55
ResistanceR$91.62
MA 20R$85.97
MA 50R$82.05
MA 200R$64.37
MACDBearish
VolumeDecreasing
Fear & Greed Index75.89
Valuation
Fair ValueR$33.74
Target PriceR$87.95
Upside/Downside10.96%
GradeOvervalued
TypeBlend
Dividend Yield8.74%
Risk Assessment
Beta0.54
Volatility38.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.